Saad Usmani's guest appearances

Saad Usmani

The Hematologist

HealthTree Podcast for Multiple Myeloma

Irene Ghobrial

Parameswaran Hari

Shaji Kumar

Stephen Russell

David Anderson

Adam Cohen

David Siegel

Mike Thompson

Beth Israel

Stephanie Lee

Damian Green

George Daley

Hassan Murad

Sarah Cannon

Keith Stewart

OwlTail

Nikhil Munshi

In this podcast, Contributing Editor Dr. Saad Usmani has a conversation with Dr. Nikhil Munshi. They discuss Dr. Usmani’s Mini Review article from the July/August 2021 issue of The Hematologist, titled, "Immune Therapies for Myeloma: The CARs Are Here but What’s Next?" They discuss the latest approvals of chimeric antigen receptor T-cell therapies to treat multiple myeloma. You can access his Mini Review article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021413/476193/Immune-Therapies-for-Myeloma-The-CARs-Are-Here-but?utm_source=sfmc&amp;utm_medium=email&amp;utm_campaign=TheHem+July+2021&amp;utm_term=Link+Text+%c2%bb&amp;utm_id=102625&amp;sfmc_id=3....Additional ASH affiliation and COI information: Dr. Usmani has received research funding from Amgen, Array Biopharma, BMS, Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX, and Takeda; consulting fees from Amgen, BMS, Celgene, EdoPharma, GSK, Janssen, Sanofi, Seattle Genetics, SecuraBio, SkylineDX, Takeda, and TeneoBio; speaker fees from Amgen, BMS, Janssen, and Sanofi.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Contributing Editor Dr. Saad Usmani has a conversation with Dr. Nikhil Munshi. They discuss Dr. Usmani’s Mini Review article from the July/August 2021 issue of The Hematologist, titled, "Immune Therapies for Myeloma: The CARs Are Here but What’s Next?" They discuss the latest approvals of chimeric antigen receptor T-cell therapies to treat multiple myeloma. You can access his Mini Review article online at <a href="https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021413/476193/Immune-Therapies-for-Myeloma-The-CARs-Are-Here-but?utm_source=sfmc&amp;utm_medium=email&amp;utm_campaign=TheHem+July+2021&amp;utm_term=Link+Text+%c2%bb&amp;utm_id=102625&amp;sfmc_id=32555314" rel="nofollow" target="_blank">https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021413/476193/Immune-Therapies-for-Myeloma-The-CARs-Are-Here-but?utm_source=sfmc&amp;utm_medium=email&amp;utm_campaign=TheHem+July+2021&amp;utm_term=Link+Text+%c2%bb&amp;utm_id=102625&amp;sfmc_id=3...</a>.<br>Additional ASH affiliation and COI information: Dr. Usmani has received research funding from Amgen, Array Biopharma, BMS, Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX, and Takeda; consulting fees from Amgen, BMS, Celgene, EdoPharma, GSK, Janssen, Sanofi, Seattle Genetics, SecuraBio, SkylineDX, Takeda, and TeneoBio; speaker fees from Amgen, BMS, Janssen, and Sanofi.<br>Music: “Jellyfish in Space” Kevin MacLeod (<a href="http://incompetech.com" rel="nofollow" target="_blank">incompetech.com</a>). Licensed under Creative Commons: By Attribution 3.0 <a href="http://creativecommons.org/licenses/by/3.0/" rel="nofollow" target="_blank">creativecommons.org/licenses/by/3.0/</a>

Immune Therapies for Myeloma, With Drs. Saad Usmani and Nikhil Munshi

Join us as we talk with Dr. Saad Usmani, MD about his new position as Director of Clinical Research for Hematologic Malignancies and Director of Plasma Cell Disorders at the Levine Cancer Institute and his clinical trials for high-risk myeloma patients. Dr. Usmani was formerly at UAMS.

mPatient Myeloma Radio: Dr. Saad Usmani, MD, Levine Cancer Institute